EGFR and non-small cell lung carcinoma: We then evaluated the anticancer effects of these compounds against A549 NSCLC and MCF-7 breast cancer cells by MTT assay and, more mechanistically, the apoptotic effects in A549 and MCF-7 cells and the EGFR inhibitory potential of the most effective compound.